What clinical trials are currently recruiting in Michigan?

TrialFinder lists 2241 recruiting clinical trials with sites in or near Michigan. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Michigan?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Michigan?

Trials in Michigan cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Michigan?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

2241 Recruiting Trials

Clinical Trials in Michigan

Browse 2241 recruiting clinical trials currently enrolling participants in Michigan. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 2241 recruiting trials in Michigan

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

N/A Bethesda, Maryland +4 sites · Primary Immune Deficiency

Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

PHASE2 Birmingham, Alabama +4 sites · Multiple Myeloma, Advanced Solid Tumors

Recruiting

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

PHASE2 Anchorage, Alaska +4 sites · Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

N/A Birmingham, Alabama +4 sites · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Recruiting

Hydrus® Microstent New Enrollment Post-Approval Study

NA Irvine, California +4 sites · Primary Open Angle Glaucoma

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

PHASE2 Birmingham, Alabama +4 sites · Wilms Tumor, Osteosarcoma

Recruiting

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

PHASE2 Birmingham, Alabama +4 sites · Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma

Recruiting

Precision-Based Genomics in Prostate Cancer

N/A La Jolla, California +4 sites · Prostate Cancer

Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

PHASE1 Los Angeles, California +4 sites · Advanced Solid Tumor

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

PHASE2 Los Angeles, California +4 sites · Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease

Recruiting

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE3 Birmingham, Alabama +4 sites · Non Small Cell Lung Cancer

Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

PHASE2 Birmingham, Alabama +4 sites · Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma

Recruiting

See all 2241 results in Michigan

Check Your Eligibility

Create a free profile and our AI will match you to trials in Michigan you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Michigan

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon